Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics
JSPR Price/Volume Stats
Current price | $23.22 | 52-week high | $31.01 |
Prev. close | $22.80 | 52-week low | $4.00 |
Day low | $22.81 | Volume | 1,922 |
Day high | $23.22 | Avg. volume | 172,718 |
50-day MA | $20.23 | Dividend yield | N/A |
200-day MA | $21.62 | Market Cap | 350.74M |
JSPR Stock Price Chart Interactive Chart >
Jasper Therapeutics, Inc., (JSPR) Company Bio
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Price Returns
1-mo | 27.02% |
3-mo | 28.43% |
6-mo | 0.87% |
1-year | 303.90% |
3-year | -73.73% |
5-year | N/A |
YTD | 194.30% |
2023 | 63.39% |
2022 | -93.85% |
2021 | -21.58% |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...